Literature DB >> 6520696

Analysis of the effect of an anti-inflammatory steroid, dexamethasone, on neutrophil chemotaxis in the Boyden chamber with a modified 51Cr-labeling method.

A Kurihara, F Ojima, S Tsurufuji.   

Abstract

For the determination of leukocyte chemotaxis in the Boyden chamber toward zymosan-activated serum, a modification of the 51Cr-labeling method originally introduced by Gallin et al. was made using a polycarbonate filter at the top of a double filter system. By application of this method, it was demonstrated that an anti-inflammatory steroid, dexamethasone at relatively low doses, directly inhibited chemotactic movement of leukocytes after the pretreatment of the cells with dexamethasone for several hours. This inhibitory effect was proved to be a common property of glucocorticoids. The leukocyte-inhibitory effect manifested within the cell body and the release of any extracellular factors mediating the inhibitory effect of the corticoid into the medium was not demonstrated. The present data suggests that the inhibitory effect of dexamethasone on leukocyte infiltration observed in vivo is attributed to the direct inhibitory effect of dexamethasone on the motility of leukocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6520696     DOI: 10.1248/bpb1978.7.747

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  3 in total

1.  Induction of neutrophil infiltration by rat chemotactic cytokine (CINC) and its inhibition by dexamethasone in rats.

Authors:  N Hirasawa; M Watanabe; S Mue; K Watanabe; S Tsurufuji; K Ohuchi
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

2.  Use of fluorochromes in the determination of chemotaxis and haptotaxis of granulocytes by micropore filter assays.

Authors:  P Schratzberger; C M Kähler; C J Wiedermann
Journal:  Ann Hematol       Date:  1996-01       Impact factor: 3.673

3.  Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.

Authors:  Fabricio Souza Neves; Solange Carrasco; Cláudia Goldenstein-Schainberg; Célio Roberto Gonçalves; Suzana Beatriz Veríssimo de Mello
Journal:  Clin Rheumatol       Date:  2009-08-25       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.